Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Respiratory involvement in IgG4-related Mikulicz's disease.
Matsui S, Taki H, Shinoda K, Suzuki K, Hayashi R, Tobe K, Tokimitsu Y, Ishida M, Fushiki H, Seto H, Fukuoka J, Ishizawa S. Matsui S, et al. Mod Rheumatol. 2012 Feb;22(1):31-9. doi: 10.1007/s10165-011-0504-x. Epub 2011 Aug 3. Mod Rheumatol. 2012. PMID: 21811890
A history of ischemic heart disease is a common cause of wheezing in the elderly of a Japanese local community.
Inomata M, Kawagishi Y, Tokui K, Masaki Y, Taka C, Kambara K, Okazawa S, Imanishi S, Ichikawa T, Suzuki K, Yamada T, Iwata M, Usui I, Sumi S, Origasa H, Matsui S, Hayashi R, Tobe K. Inomata M, et al. Among authors: matsui s. Intern Med. 2011;50(24):2975-81. doi: 10.2169/internalmedicine.50.6201. Epub 2011 Dec 15. Intern Med. 2011. PMID: 22185988 Free article.
Recurrence of IgG4-related disease following treatment with rituximab.
Murakami J, Matsui S, Ishizawa S, Arita K, Wada A, Miyazono T, Hounoki H, Shinoda K, Taki H, Sugiyama T. Murakami J, et al. Among authors: matsui s. Mod Rheumatol. 2013 Nov;23(6):1226-30. doi: 10.1007/s10165-012-0738-2. Epub 2012 Sep 6. Mod Rheumatol. 2013. PMID: 22956241
Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib.
Inomata M, Hayashi R, Tanaka H, Shimokawa K, Tokui K, Taka C, Okazawa S, Kambara K, Ichikawa T, Yamada T, Miwa T, Kashii T, Matsui S, Tobe K. Inomata M, et al. Among authors: matsui s. Mol Clin Oncol. 2016 May;4(5):774-778. doi: 10.3892/mco.2016.779. Epub 2016 Feb 16. Mol Clin Oncol. 2016. PMID: 27123277 Free PMC article.
1,448 results